<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Molecular Cloning | Protocol 7 Print Version</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1251"><!--================== Designed and Developed by WriteDesign =================--><!--======================= Powered by RomeBlack, Inc. =======================--><!--=== Copyright 2000, 2001 Cold Spring Harbor Labs. All Rights Reserved. ===-->
<META content="" name=keywords>
<META 
content="This stage summarizes how to construct a cDNA library in a mammalian vector, using commercial kits. These kits are available from several manufacturers and generally include all the required reagents." 
name=description>
<META content="MSHTML 5.50.4134.600" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff background=../izo/fon.gif>
<table width=600 border="0" cellspacing="0" cellpadding="0"><tr><td width=600><IMG height=49 hspace=4 src="../izo/logo_csh.gif" 
width=169 align=left vspace=4><IMG height=49 hspace=4 
src="../izo/print_header.gif" width=293 align=left vspace=4><BR 
clear=all><BR><FONT face="arial,verdana, helvetica" size=4><STRONG>Chapter 11, 
Protocol 7</STRONG></FONT><BR><BR clear=all><FONT face=arial,verdana,helvetica 
size=3><STRONG>Construction and Screening of Eukaryotic Expression 
Libraries<BR>Stage 1: Construction of cDNA Libraries in Eukaryotic Expression 
Vectors</STRONG></FONT><BR><BR><FONT face="arial,verdana, helvetica" size=2>This 
stage summarizes how to construct a cDNA library in a mammalian vector, using 
commercial kits. These kits are available from several manufacturers and 
generally include all the required reagents.</FONT> <BR><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD width=700><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" 
      width=11 border=0><FONT face=arial,verdana,helvetica 
      size=2><STRONG>CAUTION</STRONG></FONT><BR><IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0><FONT 
      face="arial,verdana, helvetica" size=2> <STRONG>RECIPE</STRONG></FONT> 
  </TD></TR></TBODY></TABLE><BR><BR><FONT face=arial,verdana,helvetica 
size=3><STRONG>MATERIALS</STRONG></FONT><BR><BR>
<TABLE cellPadding=0 cellborder="0">
  <TBODY>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Buffers and Solutions</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>10x Universal 
      KGB buffer (restriction endonuclease buffer[s])</FONT> <IMG height=12 
      alt="" hspace=4 src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Enzymes and Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Restriction 
      enzymes</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Please see 
      Step 3.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Nucleic Acids and Oligonucleotides</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" 
      size=2>Poly(A)<SUP>+</SUP>-enriched mRNA</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>This mRNA 
      should be isolated from a cell line or tissue that expresses the activity 
      of interest and purified by two-pass chromatography on oligo(dT) cellulose 
      (please see <A href="../07/03.htm">Chapter 
      7, Protocol 3</A>). Identification of the highest expressing tissue or 
      cell line must be accomplished empirically using the biological assay that 
      will be employed in the expression cloning screen.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Additional Reagents</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 1 of this 
      protocol requires the reagents listed in <A href="01.htm">Chapter 
      11, Protocol 1</A> to <A href="04.htm">Chapter 
      11, Protocol 4</A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 2 of this 
      protocol requires the reagents listed in <A href="05.htm">Chapter 
      11, Protocol 5</A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Steps 4 and 5 
      of this protocol require the reagents listed in <A href="06.htm">Chapter 
      11, Protocol 6</A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 8 of this 
      protocol may require the reagents listed in <A href="../01/26.htm">Chapter 
      1, Protocol 26</A>.</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Vectors and Bacterial Strains</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" 
      size=2>Electrocompetent <I>E. coli</I> cells</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>If a 
      plasmid expression vector is chosen, prepare (please see <A href="../01/26.htm">Chapter 
      1, Protocol 26</A>) or purchase electrocompetent </I>E. coli<I> as hosts 
      for the cDNA library. The titer of the electrocompetent cells should be at 
      least 5 x 10<SUP>8</SUP> colonies/µg plasmid DNA. Ideally, use a single 
      lot or preparation of cells throughout the expression cloning and 
      screening procedure.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Expression 
      vector</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>The choice 
      of (plasmid or bacteriophage <IMG src="../izo/lambda.gif" border=0> 
      expression) vector is dictated by the host system used for expression. If 
      </I>Xenopus<I> oocytes are used, the expression vector should be a 
      bacteriophage <IMG src="../izo/lambda.gif" border=0> DNA or a plasmid 
      vector DNA carrying promoters for the bacteriophage SP6, T3, or T7 
      DNA-dependent RNA polymerases flanking the polylinker (e.g., <IMG 
      src="../izo/lambda.gif" border=0>ZAP Express, <IMG 
      src="../izo/lambda.gif" border=0>ExCell, and pSPORT). If cultured 
      mammalian cells are used, then choose a plasmid-based expression vector 
      that contains a powerful promoter and a strong transcription terminator 
      sequence. Examples include the pCMV series (Stratagene) of plasmids and 
      pcDNA 4 (Invitrogen).</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Packaging 
      extracts</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>If a 
      bacteriophage <IMG src="../izo/lambda.gif" border=0> vector is chosen, 
      then purchase (or prepare) a very high titer packaging extract with which 
      to insert the recombinant cDNAs into the virus. The titer of the extract 
      should be at least 10<SUP>9</SUP> pfu/µg viral DNA.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 
  border=0></TD></TR></TBODY></TABLE><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" 
size=3><STRONG>METHOD</STRONG></FONT> <BR><FONT face="arial,verdana, helvetica" 
color=#000000 size=2>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Use a 
  commercial kit or follow the instructions in <A href="01.htm">Chapter 
  11, Protocol 1</A> to <A href="04.htm">Chapter 
  11, Protocol 4</A> to synthesize blunt-ended, double-stranded cDNA and equip 
  the termini with the appropriate linkers or adaptors. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Fractionate the 
  double-stranded cDNA according to size, using gel-filtration chromatography. 
  For details, please see <A href="05.htm">Chapter 
  11, Protocol 5</A>.<BR><I>If the size of the target mRNA is known, pool the 
  column fractions that contain double-stranded cDNAs ranging in size from 1 kb 
  smaller than the target mRNA to 1 kb larger than the target mRNA. If the size 
  of the target mRNA is unknown, fractionate the preparation of double-stranded 
  cDNA into three pools containing molecules of different sizes: 500-1500 bp, 
  1500-3000 bp, and &gt;3000 bp.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Digest 10-25 µg 
  of the plasmid or bacteriophage <IMG src="../izo/lambda.gif" border=0> 
  expression vector with two restriction enzymes whose recognition sequences 
  occur in the linker-adaptors placed at the 5' and 3' ends of the 
  cDNA.<BR><B>IMPORTANT</B><I> Take care to ensure that both restriction enzymes 
  digest the vector DNA to completion. Carry out the digestions in sequence 
  rather than simultaneously; purify the DNA by extraction with 
  phenol:chloroform and precipitation with ethanol between digests, and where 
  possible, use gel electrophoresis to check that both of the digests have gone 
  to completion.</I><BR><I>To ensure complete cleavage of the expression vector 
  before the cloning of cDNA, some investigators insert a short "stuffer" 
  fragment of 200-300 bp between the </I>Sal<I>I and </I>Not<I>I (or other 
  enzyme combination) sites of the polylinker.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Set up trial 
  ligations using different ratios of cDNA to bacteriophage <IMG 
  src="../izo/lambda.gif" border=0> arms or plasmid DNA. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Package an 
  aliquot of the products of each of the ligation reactions into bacteriophage 
  <IMG src="../izo/lambda.gif" border=0> particles. Determine the titer of 
  infectious particles generated in each packaging reaction. Alternatively, use 
  electroporation to transform <I>E. coli</I> with aliquots of each ligation 
  reaction (please see <A href="../01/26.htm">Chapter 
  1, Protocol 26</A>). </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Test six 
  bacteriophage <IMG src="../izo/lambda.gif" border=0> or plasmid recombinants 
  for the presence of cDNA inserts of the appropriate size and determine the 
  ratio of cDNA to vector DNA that generates the largest number of recombinant 
  clones. Calculate the size of the library that can be generated from the 
  ligation reactions containing the optimum ratio of cDNA to vector. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Using the 
  optimum ratio of cDNA insert to vector, ligate as much of the cDNA as possible 
  to the bacteriophage <IMG src="../izo/lambda.gif" border=0> or plasmid 
  DNA.<BR><I>It is usually better to set up many small ligation reactions, 
  rather than one large reaction.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Prepare and 
  analyze the recombinants using one of the methods below:<BR>If a bacteriophage 
  <IMG src="../izo/lambda.gif" border=0> vector is used: Package the ligated 
  cDNA into bacteriophage <IMG src="../izo/lambda.gif" border=0> particles 
  following the directions provided by the manufacturer of the packaging 
  extract, measure the titer of the virus stock, and store the stock at 4°C. 
  <BR>If a plasmid vector is used: Measure the number of potential recombinants 
  in the ligation reaction by electroporating small aliquots of the ligation 
  mixture into <I>E. coli</I> cells (please see <A href="../01/26.htm">Chapter 
  1, Protocol 26</A>). </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Proceed as soon 
  as is feasible to the screening of the eukaryotic expression library. 
  </FONT></LI></OL></FONT><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>RECIPES</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/circle.gif" width=12 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Potassium Acetate</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>5 M potassium acetate, 60 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>glacial acetic acid, 11.5 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>H<SUB>2</SUB>O, 28.5 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>The resulting solution is 
      3 M with respect to potassium and 5 M with respect to acetate. Store the 
      buffer at room temperature.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Universal KGB Buffer</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>1 M potassium 
      acetate</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>250 mM Tris-acetate (pH 
      7.6)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>100 mM magnesium acetate 
      tetrahydrate</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>5 mM <IMG 
      src="../izo/beta.gif" border=0>-mercaptoethanol</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>0.1 mg/ml bovine serum 
      albumin</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Store the 10x restriction 
      endonuclease buffer in aliquots at 
-20°C.</FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;     helvetica" size=3><STRONG>CAUTIONS</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" width=11 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>&szlig;-Mercaptoethanol </STRONG></FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">&szlig;-Mercaptoethanol (2-Mercaptoethanol) 
      HOCH<SUB>2</SUB>CH<SUB>2</SUB>SH may be fatal if inhaled or absorbed 
      through the skin and is harmful if ingested. High concentrations are 
      extremely destructive to the mucous membranes, upper respiratory tract, 
      skin, and eyes. &szlig;-Mercaptoethanol has a very foul odor. Wear appropriate 
      gloves and safety glasses. Always use in a chemical fume hood. 
  </FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>Glacial acetic acid</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">Acetic acid (concentrated) must be handled with great care. It may 
      be harmful by inhalation, ingestion, or skin absorption. Wear appropriate 
      gloves and goggles. Use in a chemical fume hood. 
</FONT></TD></TR></TBODY></TABLE><BR><BR><BR>
<OL></OL><BR><BR><BR><BR><BR><FONT face=Arial,Verdana,Helvetica 
size=1><STRONG>Copyright © 2000 by Cold Spring Harbor Laboratory Press. All 
rights reserved.</STRONG><BR>No part of these pages, either text or image may be 
used for any purpose other than personal use. Therefore, reproduction 
modification, storage in a retrieval system or retransmission, in any form or by 
any means, electronic, mechanical, or otherwise, for reasons other than personal 
use, is strictly prohibited without prior written 
permission.</FONT><BR><BR>
</td></tr></table>
</BODY></HTML>
